SOURCE: www.hdrc.org

[youtube=http://www.youtube.com/watch?v=x542DALvFos]

REFERENCES

1. Blamire, Professor, John. “Genotype and Phenotype.” Science At Distance. 2000. 15 Mar. 2007

http://www.brooklyn.cuny.edu/bc/ahp/BioInfo/GP/Definition.html

2. Rauch, MD, Daniel, “Fetal Development.” Medline Plus. 10 Apr. 2006. Pediatric Hospitalist Program, NYU School of Medicine, New York, NY, 11 Sept. 2007

http://www.nlm.nih.gov/medlineplus/ency/article/002398.htm

3. Arey, Leslie B. : DEVELOPMENTAL ANATOMY (a TEXTBOOK AND LABORATORY MANUAL OF EMBRYOLOGY). Revised Seventh Edition ed. Philadelphia,

PA.: W.B. Saunders Company, 1974. 695. (Page 86)

4. Moore, B.a., M.sc., Ph.d., F.i.a.c., F.r.s.m, Keith L., and T.v.n Persuad, M.d., Ph.d., D.sc., F.r.c.path. (lond). The Developing Human. 5th ed. Philadelphia, PA:

W.B. Saunders Company, 1993. 492. (Page 65)

5. Who Technical Consultation. Safe Abortion: Technical and Policy Guidance for Health Systems. Geneva: World Health Organization, 2003. Special programme

of research, Development and research training in human reproduction. 103 pp. (page 22)

http://www.who.int/reproductive-health/publications/safe_abortion/

6. “FDA Public Health Advisory Sepsis and Medical Abortion.” Federal Drug Administration. 04 Nov. 2005. FDA/Center for Drug Analysis and Research. 15 July

2006 <http://www.fda.gov/cder/drug/advisory/mifeprex.htm>.

7. Corson, M.d., Stephen L., Richard J. Derman, M.d., and Louise B. Tyrer, M.d., eds. Fertility Control. 2th ed. Canada: Goldin, 1994. 514. (page 419)

8. Mayo Clinic Staff, comp. “Mifepristone” Mayo Clinic.Com. 7 October 2005. Mayo Foundation for Education and Medical Research. 10 June 2006-<http://www.mayoclinic.com/health/search/drugSearch/keywords=mifepristone

9. “Patient Medication Guide.” earlyoptionpill.Com. 19 June 2005. pg. 9 Danco Laboratories, LLC, NY, NY. 10 Jan. 2006 <http://www.earlyoptionpill.com/pdfs/prescribing071905.pdf>.

10. Who Technical Consultation. Safe Abortion: Technical and Policy Guidance for Health Systems. Geneva: World Health Organization, 2003. Special programme

of research, Development and research training in human reproduction. 103 pp. (page 35)

http://www.who.int/reproductive-health/publications/safe_abortion/

11. “Patient Medication Guide.” earlyoptionpill.Com. 19 June 2005. pg. 9 Danco Laboratories, LLC, NY, NY. 10 Jan. 2006 <http://www.earlyoptionpill.com/pdfs/prescribing071905.pdf>.

12. Spitz, IM, CW Bardin, L Benton, and A Robbins. “Early pregnancy termination with mifepristone and misoprostol in the U.S.”. New England Journal of Medicine.

18 (1998): 1241-1247. Entrez PubMed. National Library of Medicine and the National Institute of Health. 18 July 2006 <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=Abstract&list_uids=9562577&query_hl=99&itool=pubmed_docsum>.

13. Henshaw, R, S Nija, I Russell, and A Templeton. “Psychological Responses Following Medical Abortion (Using Mifepristone and Gemeprost) and Surgical

Vacuum Aspiration. a Patient-Centered, Partially Randomised Prospective Study.” Acta Obstet Gynecol Scand. 73 (1994): 812-818. Entrez PubMed. National

Library of Medicine/National Institute of Health. 9 June 2006 <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=Abstract&list_uids=7817735&query_hl=99&itool=pubmed_docsum

14. Holmgren, K. “Women’s Evaluation of Three Early Abortion Methods.” Acta Obstetricria Gynocologica Scandinovica 71 (1992): 616-623. Entrez PubMed.

National Library of Medicine/National Institute of Health. 20 June 2005 <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=Abstract&list_uids=1336921&query_hl=99&itool=pubmed_DocSum

15. Danco Laboratories, Llc (. “MIFEPREX® (Mifepristone) Tablets, 200 Mg.” Food and Drug Administration Home Page. 19 July 2005. 2 May 2007

http://www.fda.gov/cder/foi/label/2005/020687s013lbl.pdf

16. “Patient Information Sheet Mifepristone (Marked Mifeprex).” Federal Drug Administration. July 2005. FDA/Center for Drug Evaluation and Research. 22

June 2006 <http://www.fda.gov/cder/drug/InfoSheets/patient/mifepristonePIS.pdf>.

17. United States. Center for Drug Evaluation and Research. Federal Drug Administration. Mifeprex Label. 17 July 2005. 21 July 2006 <http://www.fda.gov/cder/ foi/label/2005/020687s013lbl.pdf>.

18. Danco Laboratories, Llc (. “MIFEPREX® (Mifepristone) Tablets, 200 Mg.” Food and Drug Administration Home Page. 19 July 2005. 2 May 2007

http://www.fda.gov/cder/foi/label/2005/020687s013lbl.pdf

 

©HDRC, Inc. 2008 Human Development Resource Council www.hdrc.org. For educational purposes only. This information
should not be used for the diagnosis or treatment of any medical condition. Consult a licensed physician for
diagnosis and treatment of any and all medical conditions. JTFDVDBIBEn: Updated 8-07

Source:

http://hdrc.org/library.aspx?categoryid=200&languageid=1&resourceid=26&#26

This entry was posted on Friday, October 14th, 2011 at 2:03 pm and is filed under News & Commentary. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.